Technology area: Biotechnology & Pharmaceuticals
6 pending office actions • 6 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Cybin Irl Limited has 6 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 6 distinct examiners and 6 distinct art units, showing that each pending matter follows its own recorded examination path.
SAEED, KAMAL A is the busiest examiner, with 1 pending matter. Since the examiner and art-unit assignments are fully distributed, counsel should focus on the individual claim issues and prosecution histories rather than seek efficiencies from a shared examination setting.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 3 (50%) |
| Double-patenting + other | 1 (17%) |
| Multi-statute (no §101) | 1 (17%) |
| No statute on record | 1 (17%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SAEED, KAMAL A | 1 | 83.9% | +9.8% |
| VALENROD, YEVGENY | 1 | 72.6% | +25.0% |
| LEE, SIN J | 1 | 68.7% | +25.2% |
| ABDALHAMEED, MANAHIL MIRGHANI ALI | 1 | 50.3% | +39.1% |
| LUAN, SCOTT | 1 | 65.6% | +11.6% |
| MCDOWELL, BRIAN E | 1 | 74.0% | +31.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18707825 | FORMULATIONS OF PSILOCYBIN ANALOGS AND METHODS OF USE | VALENROD, YEVGENY | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18561152 | FORMULATIONS OF PSILOCYBIN | MCDOWELL, BRIAN E | 72d |
| 18707825 | FORMULATIONS OF PSILOCYBIN ANALOGS AND METHODS OF USE | VALENROD, YEVGENY | — |
| 18688125 | COMBINATION DRUG THERAPIES | LEE, SIN J | — |
| 18588132 | METHODS OF TREATING DISORDERS WITH A PSILOCYBIN ANALOG | ABDALHAMEED, MANAHIL MIRGHANI ALI | — |
| 18576487 | INTEGRATED DATA COLLECTION DEVICES FOR USE IN VARIOUS THERAPEUTIC AND WELLNESS APPLICATIONS | LUAN, SCOTT | — |
| Art Unit | Apps |
|---|---|
| 1626 | 1 |
| 1628 | 1 |
| 1613 | 1 |
| 1622 | 1 |
| 3792 | 1 |
| 1624 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18883262 | DEUTERATED TRYPTAMINE DERIVATIVES AND METHODS OF USE | SAEED, KAMAL A | 1626 | Other | Non-Final OA | — | Pending | Sep 12, 2024 |
| 18707825 | FORMULATIONS OF PSILOCYBIN ANALOGS AND METHODS OF USE | VALENROD, YEVGENY | 1628 | §103§112 | Non-Final OA | — | Pending | May 06, 2024 |
| 18688125 | COMBINATION DRUG THERAPIES | LEE, SIN J | 1613 | §103DP | Final Rejection | — | Pending | Feb 29, 2024 |
| 18588132 | METHODS OF TREATING DISORDERS WITH A PSILOCYBIN ANALOG | ABDALHAMEED, MANAHIL MIRGHANI ALI | 1622 | §103Other | Non-Final OA | — | Pending | Feb 27, 2024 |
| 18576487 | INTEGRATED DATA COLLECTION DEVICES FOR USE IN VARIOUS THERAPEUTIC AND WELLNESS APPLICATIONS | LUAN, SCOTT | 3792 | §103 | Non-Final OA | — | Pending | Jan 04, 2024 |
| 18561152 | FORMULATIONS OF PSILOCYBIN | MCDOWELL, BRIAN E | 1624 | §103Other | Final Rejection | 72d | Pending | Nov 15, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialCybin Irl Limited has 6 pending office actions as of November 2026, spread across 6 art units and 6 examiners.
Kamal A Saeed has the most, with 1 of Cybin Irl Limited's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.